Tofacitinib-d3
Tofacitinib-d3 (Tasocitinib-d3) is deuterium labeled Tofacitinib. Tofacitinib is an orally available JAK3/2/1 inhibitor with IC50s of 1, 20, and 112 nM, respectively.
Product Specifications
Product Name Alternative
Tasocitinib-d3; CP-690550-d3
UNSPSC
12352005
Target
Isotope-Labeled Compounds
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cancer
Smiles
O=C(N1C[C@@H]([C@@H](CC1)C)N(C([2H])([2H])[2H])C2=C3C(NC=C3)=NC=N2)CC#N
Molecular Formula
C16H17D3N6O
Molecular Weight
315.39
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx309783-01 20 µg
Protein Tyrosine Phosphatase Type IVA 1 (PTP4A1) Antibody
Sign In for Pricing
View Details abx309783-02 50 µg
Protein Tyrosine Phosphatase Type IVA 1 (PTP4A1) Antibody
Sign In for Pricing
View Details abx309783-03 100 µg
Protein Tyrosine Phosphatase Type IVA 1 (PTP4A1) Antibody
Sign In for Pricing
View Details abx309783-04 200 µg
Protein Tyrosine Phosphatase Type IVA 1 (PTP4A1) Antibody
Sign In for Pricing
View Details abx309783-05 1 mg
Protein Tyrosine Phosphatase Type IVA 1 (PTP4A1) Antibody
Sign In for Pricing
View Details